Clincosm LogoSign in Get a demo

Esophageal Cancer

Showing 76 - 100 of 805
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunochemotherapy in Esophageal Cancer

Recruiting
  • Esophageal Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Nov 24, 2022

    Fragments for Early Interception - Lung Cancer Training Study

    Recruiting
    • Lung Cancer
    • +8 more
    • Blood Sample Collection
    • New York, New York
    • +1 more
    Nov 28, 2022

    Esophageal Cancer Trial (Tislelizumab, Radiation, Paclitaxel)

    Not yet recruiting
    • Esophageal Cancer
    • (no location specified)
    Nov 18, 2022

    Pancreatic Cancer, Esophageal Cancer, Gastric Cancer Trial in Boston (Usual Care, Perioperative Geriatrics Intervention)

    Completed
    • Pancreatic Cancer
    • +5 more
    • Usual Care
    • Perioperative Geriatrics Intervention
    • Boston, Massachusetts
      Massachusetts general Hospital
    Nov 18, 2022

    Two-field or Three-field Lymphadenectomy on Overall Survival in

    Completed
    • Esophageal Cancer
    • Since the data were collected retrospectively, there were no interventions
    • Chendu, Sichuan, China
      Sichuan Cancer Hospital
    Nov 18, 2022

    Squamous Cell Esophageal Carcinoma, Esophageal Cancer, Oesophageal Cancer Trial in Guangzhou (drug, radiation, procedure)

    Recruiting
    • Squamous Cell Esophageal Carcinoma
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 11, 2022

    Validation for Early Cancer Detection and Minimal Residual

    Recruiting
    • Brain Cancer
    • +19 more
      • Duarte, California
      • +6 more
      Nov 10, 2022

      Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET

      Active, not recruiting
      • Esophageal Cancer
      • MR, PET CT
      • Ljubljana, Slovenia
        Institute of Oncology
      Nov 3, 2022

      Esophageal Cancer, Surgery, Jejunostomy; Complications Trial in Seoul (Jejunostomy feeding)

      Completed
      • Esophageal Cancer
      • +3 more
      • Jejunostomy feeding
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Nov 8, 2022

      Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

      Available
      • Pancreatic Cancer
      • +20 more
      • Ulixertinib (BVD-523)
      • Birmingham, Alabama
      • +25 more
      Nov 4, 2022

      Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

      Recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • +11 more
      • New Haven, Connecticut
      • +12 more
      Nov 3, 2022

      Index of Lymphadenectomy for Thoracic Escc

      Completed
      • Esophageal Cancer
        • Chengdu, Sichuan, China
          Sichuan Cancer Hospital and Research Institute
        Nov 3, 2022

        Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

        Recruiting
        • Advanced Solid Tumor
        • +24 more
        • MDNA11 Monotherapy
        • MDNA11 in combination with checkpoint inhibitor
        • Santa Monica, California
        • +7 more
        Nov 1, 2022

        Respiratory Tract Dysplasia or Lung Cancer, Head and Neck

        Recruiting
        • Esophageal Cancer
        • +3 more
        • immunohistochemistry staining method
        • +3 more
        • Aurora, Colorado
          University of Colorado Cancer Center at UC Health Sciences Cente
        Nov 1, 2022

        Blood, Urine, and Bone Marrow

        Recruiting
        • Non Small Cell Lung Cancer
        • +5 more
        • Test for circulating tumor cells, DNA alterations
        • Columbia, Missouri
          Harry S Truman Veterans Memorial Hospital
        Oct 31, 2022

        Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

        Recruiting
        • Adenocarcinoma
        • +75 more
        • Biomarker Testing (L)
        • +2 more
        • Idaho Falls, Idaho
        • +1 more
        Oct 18, 2022

        Esophageal Cancer Trial in Houston (Proton Beam Therapy (PBT), Intensity Modulated Radiation Therapy (IMRT), Questionnaires)

        Active, not recruiting
        • Esophageal Cancer
        • Proton Beam Therapy (PBT)
        • +2 more
        • Houston, Texas
          MD Anderson Cancer Center
        Oct 11, 2022

        Systems Biology of Gastrointestinal and Related Diseases

        Not yet recruiting
        • Ulcerative Colitis
        • +21 more
          • Bothell, Washington
            Viome Life Sciences
          Oct 10, 2022

          Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)

          Completed
          Has Results
          • Prostate Cancer
          • +4 more
          • NY-ESO-1 Plasmid DNA Cancer Vaccine
          • New York, New York
          • +1 more
          Oct 3, 2022

          Esophageal Cancer, Surgery, Neoadjuvant Treatment Trial in Zhengzhou (Neoadjuvant immunochemo)

          Recruiting
          • Esophageal Cancer
          • +3 more
          • Neoadjuvant immunochemotherapy
          • Zhengzhou, Henan, China
            Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
          Oct 2, 2022

          Esophageal Cancer Trial in Moscow (Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.,

          Recruiting
          • Esophageal Cancer
          • Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.
          • Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy
          • Moscow, Russian Federation
            N.N. Blokhin National Medical Research Center of Oncology
          Oct 2, 2022

          Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

          Not yet recruiting
          • Cervical Cancer
          • +13 more
          • (no location specified)
          Sep 28, 2022

          Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

          Completed
          • Melanoma
          • +25 more
          • Scottsdale, Arizona
          • +10 more
          Sep 27, 2022

          Esophageal Cancer Trial (OBI-833/OBI-821)

          Recruiting
          • Esophageal Cancer
          • OBI-833/OBI-821
          • Taipei, Taiwan
            National Taiwan University Hospital
          Sep 22, 2022

          Esophageal cAncer Screening Trial

          Completed
          • Esophageal Squamous Cell Carcinoma
          • +2 more
          • Sponge cytological test
          • Shanghai, Shanghai, China
            Changhai Hospital
          Sep 17, 2022